Summary
Updated Aug 31, 2026
Timothy P. Lynch is 10% Owner of AEON Biopharma, Inc. (AEON). 1 SEC Form 4 filing on record, dated 21 August 2026. Most recent open-market trade: bought $243K of AEON on 21 August 2026. Lifetime open-market purchases: $243K.
Recent Transactions
1Every recent SEC Form 4 transaction Timothy P. Lynch has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Timothy P. Lynch's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Fairmount Funds Management LLC - $399.66M of SYRE open-market activity in the last 12 months
- Robert M. Williams Jr. - $371.84M of AVAH open-market activity in the last 12 months
- Paul R. Vigano - $371.84M of AVAH open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $327.32M of CELC open-market activity in the last 12 months
- J.H. Whitney Equity Partners VII, LLC - $319.15M of AVAH open-market activity in the last 12 months
- GENERAL ATLANTIC, L.P. - $315.49M of ALHC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Timothy P. Lynch?
Timothy P. Lynch is a corporate insider, tracked as 10% Owner of AEON Biopharma, Inc. (AEON). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Timothy P. Lynch submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Timothy P. Lynch been buying or selling stock?
Recorded transactions: 1 open-market purchase ($243K) and 0 open-market sales across all tracked filings.
Where can I see all of Timothy P. Lynch's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Timothy P. Lynch and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial